L&C BIO Co.,LTD (KOSDAQ:290650)

L&C BIO Co.,LTD Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	79,992	72,093	65,927	52,572	45,677	32,973
Other Revenue	-	-0	-	-0	-	-
Revenue	79,992	72,093	65,927	52,572	45,677	32,973
Revenue Growth (YoY)	19.41%	9.35%	25.40%	15.10%	38.53%	13.11%
Cost of Revenue	38,632	36,364	32,070	25,581	17,227	13,414
Gross Profit	41,360	35,729	33,856	26,992	28,450	19,558
Selling, General & Admin	32,373	25,863	20,476	13,941	12,057	9,555
Research & Development	5,265	4,907	3,152	2,195	2,295	2,381
Amortization of Goodwill & Intangibles	540.89	471.04	395.16	358.64	238.28	68.98
Operating Expenses	41,242	33,187	25,727	17,508	15,280	12,234
Operating Income	117.56	2,542	8,129	9,484	13,170	7,324
Interest Expense	-3,221	-3,221	-6,173	-3,076	-460.27	-743.24
Interest & Investment Income	1,620	1,620	1,551	666.06	431.77	832.3
Currency Exchange Gain (Loss)	-834.65	-834.65	185.28	-271.63	-58.41	-0.73
Other Non Operating Income (Expenses)	-64,464	186.49	85.1	231.71	302.06	16.38
EBT Excluding Unusual Items	-66,783	292.55	3,778	7,034	13,385	7,429
Gain (Loss) on Sale of Investments	138,950	137,710	61,740	-2,546	3,667	5,516
Gain (Loss) on Sale of Assets	-210.53	-210.53	170.77	75.75	42.98	-
Asset Writedown	-	-	-2,423	-	-	-
Pretax Income	71,957	137,792	63,266	4,563	17,095	12,944
Income Tax Expense	-6,248	-5,445	14,407	-1,129	1,515	795.51
Earnings From Continuing Operations	78,204	143,237	48,859	5,692	15,580	12,149
Earnings From Discontinued Operations	-706.22	-2,272	-328	-	-	-
Net Income to Company	77,498	140,965	48,531	5,692	15,580	12,149
Minority Interest in Earnings	501.64	99.14	-170.47	-1,148	-1,766	-1,336
Net Income	78,000	141,064	48,361	4,544	13,814	10,813
Net Income to Common	78,000	141,064	48,361	4,544	13,814	10,813
Net Income Growth	-	191.69%	964.24%	-67.11%	27.76%	49.15%
Shares Outstanding (Basic)	23	23	23	23	22	22
Shares Outstanding (Diluted)	26	25	25	23	22	22
Shares Change (YoY)	14.05%	1.90%	8.98%	1.74%	1.83%	-0.33%
EPS (Basic)	3338.21	6218.42	2131.86	200.32	619.55	493.83
EPS (Diluted)	3050.54	5637.05	2093.45	200.00	619.55	493.83
EPS Growth	-	169.27%	946.73%	-67.72%	25.46%	49.65%
Free Cash Flow	334.36	-13,282	-36,636	-43,607	655.69	4,403
Free Cash Flow Per Share	12.92	-527.25	-1481.90	-1922.29	29.41	201.07
Dividend Per Share	50.000	50.000	-	-	-	-
Gross Margin	51.70%	49.56%	51.35%	51.34%	62.29%	59.32%
Operating Margin	0.15%	3.53%	12.33%	18.04%	28.83%	22.21%
Profit Margin	97.51%	195.67%	73.36%	8.64%	30.24%	32.79%
Free Cash Flow Margin	0.42%	-18.42%	-55.57%	-82.95%	1.44%	13.35%
EBITDA	7,500	9,296	13,784	13,992	16,072	8,911
EBITDA Margin	9.38%	12.90%	20.91%	26.61%	35.19%	27.03%
D&A For EBITDA	7,382	6,754	5,654	4,508	2,902	1,587
EBIT	117.56	2,542	8,129	9,484	13,170	7,324
EBIT Margin	0.15%	3.53%	12.33%	18.04%	28.83%	22.21%
Effective Tax Rate	-	-	22.77%	-	8.86%	6.15%
Advertising Expenses	-	1,608	1,336	723.78	363.15	192.93

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.